Novartis Investigative Site

Neunkirchen 66539

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Heart Failure With Reduced Ejection Fraction, Neoplasms, Breast

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early